C2‐α‐Dicarbonyl‐Mediated Intravasation‐Cognate Matrix Microenvironmental Glycation Privileges Cancer Cell Survival Over Endothelia
Advanced Biology · 2026-11 · 10 (11)
DOI: 10.1002/adbi.70167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, online erschienen am 10.11.2026. Verfasst von Bidita Samanta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Indian Institute of Science, Bengaluru, India. Hauptthemen laut MEDLINE: Tumor Microenvironment, Deoxyglucose, Extracellular Matrix, Pyruvaldehyde. Die Arbeit nennt 72 Literaturangaben. Gefördert von: Wellcome Trust/DBT India Alliance Fellowship/Grant, Indo-French Centre for the Promotion of Advanced Research, Indian Council of Medical Research.
Abstract (Originalsprache)
Aging and diabetes, risk factors for cancer, are characterized by high tissue levels of several dicarbonyl species; understanding their relative toxicity can help design targeted strategies. We hypothesize that contextual effects of distinct dicarbonyls on extracellular matrices (ECM) differentially tweak the homeostasis of transformed and untransformed cell niches within intravasative tumor microenvironments consisting of ECM, endothelia, and cancer cells. We show how glycation by three best‐studied dicarbonyls: the C2‐α‐dicarbonyls methylglyoxal (MGO) and glyoxal (GO), and the C6‐α‐dicarbonyl 3‐deoxyglucosone (3‐DG), of two ECMs: Collagen I and laminin‐rich basement membrane (lrBM), differentially alters their morphodynamic interactions with untransformed human endothelia TeloHAEC and aggressive triple negative breast cancer MDA‐MB‐231 cells. We identify disruption in endothelial morphogenesis and adhesion, an increase in cancer cell de‐adhesion, and motility dynamics upon exposure of lrBM to C2‐α‐dicarbonyls, but not 3‐DG. This is due to dissolution of the migration‐inhibitive ECM by glycation. Similar effects are observed on Collagen I substrata due to matrix hyperpolymerization through picrosirius staining. Decreased adhesion not only ensures relative viability of cancer cells over endothelia; the latter exposed to C2‐α‐dicarbonyl‐glycated ECM exhibit even greater cell death. In summary, C2‐α‐dicarbonyls specifically can privilege the survival of cancer cells over endothelia through altering ECM adhesion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Indian Institute of Science, Bengaluru, India.
- Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, India.
- Centre for Nano Science and Engineering, Indian Institute of Science, Bengaluru, India.
ORCID-Profile: Bidita Samanta, Gaurav Ashok, Prosenjit Sen, Ramray Bhat
Förderung
- Wellcome Trust/DBT India Alliance Fellowship/Grant
- Indo-French Centre for the Promotion of Advanced Research
- Indian Council of Medical Research
- Department of Biotechnology, Ministry of Science and Technology, India
- Prime Ministers Research Fellowship
- Longevity India Initiative
- Ministry of Electronics and Information Technology (MEITy)
Zitieren
APA
Samanta, B., Ashok, G., Sen, P., & Bhat, R. (2026). C2‐α‐Dicarbonyl‐Mediated Intravasation‐Cognate Matrix Microenvironmental Glycation Privileges Cancer Cell Survival Over Endothelia. Advanced Biology, 10(11). https://doi.org/10.1002/adbi.70167
Vancouver
Samanta B, Ashok G, Sen P, Bhat R. C2‐α‐Dicarbonyl‐Mediated Intravasation‐Cognate Matrix Microenvironmental Glycation Privileges Cancer Cell Survival Over Endothelia. Advanced Biology. 2026;10(11). doi:10.1002/adbi.70167
BibTeX
@article{Samanta2026,
author = {Samanta, Bidita and Ashok, Gaurav and Sen, Prosenjit and Bhat, Ramray},
title = {C2‐α‐Dicarbonyl‐Mediated Intravasation‐Cognate Matrix Microenvironmental Glycation Privileges Cancer Cell Survival Over Endothelia},
journal = {Advanced Biology},
year = {2026},
volume = {10},
number = {11},
doi = {10.1002/adbi.70167}
}
EUVIMED